Format

Send to

Choose Destination
Res Vet Sci. 2017 Feb;110:60-64. doi: 10.1016/j.rvsc.2016.11.003. Epub 2016 Nov 6.

In Vitro effects of tamoxifen on equine neutrophils.

Author information

1
Department of Pharmacology, Faculty of Veterinary Science, Universidad Austral de Chile, Valdivia, Chile.
2
Department of Immunology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile.
3
Department of Physiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile.
4
Department of Veterinary Clinical Sciences, Faculty of Veterinary Science, Universidad Austral de Chile, Valdivia, Chile.
5
Department of Pharmacology, Faculty of Veterinary Science, Universidad Austral de Chile, Valdivia, Chile. Electronic address: gmoran@uach.cl.

Abstract

Neutrophils participate in innate immunity as the first line of host defense against microorganisms. However, exacerbated neutrophil activity can be harmful to surrounding tissues; this is important in a range of diseases, including allergic asthma and chronic obstructive pulmonary disease in humans, and equine asthma (also known as recurrent airway obstruction (RAO). Tamoxifen (TX) is a non-steroidal estrogen receptor modulator with effects on cell growth and survival. Previous preliminary studies showed that TX treatment in horses with induced acute pulmonary inflammation promoted early apoptosis of blood and BALF neutrophils, reduction of BALF neutrophils, and improvement in animals' clinical status. The aim of this study was to evaluate the in vitro effect of TX on functional tests in equine peripheral blood neutrophils. Chemotaxis, respiratory burst production and phagocytosis assays were performed on neutrophils isolated from peripheral blood samples from 10 healthy horses. Results showed that IL-8 stimulated cells decrease their chemotactic index when treated with TX (1 and 10μM). Respiratory burst production was also dampened after treatment with TX. In conclusion, these results confirm that tamoxifen has a direct action on equine peripheral blood neutrophils. However, more in vivo and in vitro studies are required to fully understand the mechanisms of action of TX on neutrophils, in order to elucidate if it can be used as treatment in disorders such as allergic asthma in humans and horses.

KEYWORDS:

Asthma; Chemotaxis; Horses; Recurrent airway obstruction; Respiratory burst; Tamoxifen

PMID:
28159238
DOI:
10.1016/j.rvsc.2016.11.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center